| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |